Tom Marcelissen

2.3k total citations · 1 hit paper
62 papers, 1.5k citations indexed

About

Tom Marcelissen is a scholar working on Urology, Rheumatology and Epidemiology. According to data from OpenAlex, Tom Marcelissen has authored 62 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Urology, 43 papers in Rheumatology and 16 papers in Epidemiology. Recurrent topics in Tom Marcelissen's work include Pelvic floor disorders treatments (43 papers), Urinary Bladder and Prostate Research (43 papers) and Urinary Tract Infections Management (15 papers). Tom Marcelissen is often cited by papers focused on Pelvic floor disorders treatments (43 papers), Urinary Bladder and Prostate Research (43 papers) and Urinary Tract Infections Management (15 papers). Tom Marcelissen collaborates with scholars based in Netherlands, United Kingdom and Germany. Tom Marcelissen's co-authors include Philip E.V. van Kerrebroeck, Stefan De Wachter, Mohammad Sajjad Rahnama’i, Philip Van Kerrebroeck, Kevin Rademakers, Matthias Oelke, Randall K. Leong, Vincent Tse, Howard B. Goldman and Rizwan Hamid and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Urology and BMJ Open.

In The Last Decade

Tom Marcelissen

57 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction

2019 491 citations Carlos Arturo Levi D’Ancona, Bernard T. Haylen et al. Neurourology and Urodynamics profile →

Peers

Countries citing papers authored by Tom Marcelissen

Since Specialization

Citations

This map shows the geographic impact of Tom Marcelissen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Marcelissen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Marcelissen more than expected).

Fields of papers citing papers by Tom Marcelissen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Marcelissen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Marcelissen. The network helps show where Tom Marcelissen may publish in the future.

Co-authorship network of co-authors of Tom Marcelissen

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Marcelissen. A scholar is included among the top collaborators of Tom Marcelissen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Marcelissen. Tom Marcelissen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Renal cell carcinoma detection: a systematic review in diagnostic urinary biomarkers 2025 ·BMC Cancer ·John J. Kelly, Iryna Samarska, Bram Ramaekers, Tom Marcelissen, Joep G.H. van Roermund, Maureen J.B. Aarts, Thomas Kerkhofs, (unknown), Frits van Osch, Tim De Meyer, Leo J. Schouten, Kim M. Smits	0
2	Modeling-Based Decision Support System for Radical Prostatectomy Versus External Beam Radiotherapy for Prostate Cancer Incorporating an In Silico Clinical Trial and a Cost–Utility Study 2021 ·Cancers ·Yvonka van Wijk, Bram Ramaekers, Ben Vanneste, Iva Halilaj, Cary Oberije, Avishek Chatterjee, Tom Marcelissen, Arthur Jochems, Henry C. Woodruff, Philippe Lambin	2
3	Current Management of Post-radical Prostatectomy Urinary Incontinence 2021 ·Frontiers in Surgery ·Mohammad Sajjad Rahnama’i, Tom Marcelissen, Bogdan Geavlete, Manuela Tutolo, Tanja Hüsch	37
4	Is prostate cancer radiotherapy using implantable rectum spacers safe and effective in inflammatory bowel disease patients? 2021 ·Clinical and Translational Radiation Oncology ·Ben Vanneste, Evert J. Van Limbergen, Tom Marcelissen, Kobe Reynders, Jarno Melenhorst, Joep G.H. van Roermund, Ludy Lutgens	6
5	Can multicentre urodynamic studies provide high quality evidence for the clinical effectiveness of urodynamics? ICI‐RS 2019 2020 ·Neurourology and Urodynamics ·Kevin Rademakers, Andrew Gammie, (unknown), Linda Cardozo, Tamsin Greenwell, Chris Harding, Ruth Kirschner‐Hermanns, Tom Marcelissen, Enrico Finazzi Agrò	1
6	Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials 2020 ·European Urology Focus ·Giorgio Ivan Russo, (unknown), Marina Di Mauro, Giovanni Cacciamani, Maarten Albersen, Georgios Hatzichristodoulou, Mikkel Fode, Paolo Capogrosso, Sebastiano Cimino, Tom Marcelissen, Jean Nicolas Cornu, Mauro Gacci, Andrea Minervini, Andrea Cocci	25
7	Do functional changes occur in the bladder due to bladder outlet obstruction? ‐ ICI‐RS 2018 2019 ·Neurourology and Urodynamics ·J.L.H. Ruud Bosch, Paul Abrams, Márcio Augusto Averbeck, Enrico Finazzi Agrò, Andrew Gammie, Tom Marcelissen, Eskinder Solomon	33
8	The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction breakdown → 2019 ·Neurourology and Urodynamics ·Carlos Arturo Levi D’Ancona, Bernard T. Haylen, Matthias Oelke, Luís Abranches Monteiro, E. P. Arnold, Howard B. Goldman, Rizwan Hamid, Yukio Homma, Tom Marcelissen, Kevin Rademakers, Alexis Schizas, Ajay Singla, (unknown), Vincent Tse, Stefan De Wachter, Sender Herschorn	491
9	The discrepancy between European Association of Urology (EAU) guidelines and daily practice in the evaluation and management of nocturia: results of a Dutch survey 2019 ·World Journal of Urology ·Mohammad Sajjad Rahnama’i, Desiree Vrijens, Sakineh Hajebrahimi, Gommert A. van Koeveringe, Tom Marcelissen	2
10	The Value of Ambulatory Urodynamics in the Evaluation of Treatment Effect of Sacral Neuromodulation 2019 ·Urologia Internationalis ·(unknown), Kevin Rademakers, Mohammad Sajjad Rahnama’i, Tom Marcelissen, Philip Van Kerrebroeck, Gommert A. van Koeveringe	9
11	Do we understand voiding dysfunction in women? Current understanding and future perspectives: ICI‐RS 2017 2018 ·Neurourology and Urodynamics ·Jalesh N. Panicker, Ralf Anding, Salvador Arlandis, Bertil Blok, Caroline A. Dorrepaal, Chris Harding, Tom Marcelissen, Kevin Rademakers, Paul Abrams, Apostolos Apostolidis	25
12	What Is New with Sexual Side Effects After Transurethral Male Lower Urinary Tract Symptom Surgery? 2018 ·European Urology Focus ·Malte Rieken, Tiago Antunes‐Lopes, Bogdan Geavlete, Tom Marcelissen	12
13	Oral Pharmacologic Management of Overactive Bladder Syndrome: Where Do We Stand? 2018 ·European Urology Focus ·Tom Marcelissen, Tina Rashid, (unknown), Nicolas Barry Delongchamps, Bogdan Geavlete, Malte Rieken, Jean‐Nicolas Cornu, Mohammad Sajjad Rahnama’i	10
14	Optimal Lead Positioning in Sacral Neuromodulation: Which Factors Are Related to Treatment Outcome? 2017 ·Neuromodulation Technology at the Neural Interface ·(unknown), Tom Marcelissen, Gommert A. van Koeveringe, Philip Van Kerrebroeck	13
15	Reduction of Nocturia in Patients Treated with C-PAP for Obstructive Sleep Apnea Syndrome 2016 ·Neurourology and Urodynamics ·Mohammad Sajjad Rahnama’i, (unknown), Tim M. J. Ewoldt, Tom Marcelissen, Michiel H. M. Gronenschild, Peter de Vries	1
16	Long-term follow-up of intravesical botulinum toxin-A injections in women with idiopathic overactive bladder symptoms 2016 ·World Journal of Urology ·Tom Marcelissen, Mohammad Sajjad Rahnama’i, (unknown), Brigitte Schurch, Peter de Vries	31
17	Is on‐demand sacral neuromodulation in patients with OAB syndrome a feasible therapy regime? 2011 ·Neurourology and Urodynamics ·Dennis Oerlemans, A.C. van Voskuilen, Tom Marcelissen, E.H.J. Weil, Rob A. de Bie, Philip E.V. van Kerrebroeck	14
18	Sacral neuromodulation for lower urinary tract dysfunction 2011 ·World Journal of Urology ·Philip E.V. van Kerrebroeck, Tom Marcelissen	36
19	Sacral neuromodulation as a treatment for neuropathic clitoral pain after abdominal hysterectomy 2010 ·International Urogynecology Journal ·Tom Marcelissen, Philip E.V.A. van Kerrebroeck, Stefan De Wachter	13
20	Primary temporal bone secretory meningioma presenting as chronic otitis media 2008 ·European Archives of Oto-Rhino-Laryngology ·Tom Marcelissen, R.B.J. de Bondt, Martin Lammens, J. J. Manni	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact